+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

High-Throughput Screening by Nuclear Magnetic Resonance (HTS by NMR) for the Identification of PPIs Antagonists



High-Throughput Screening by Nuclear Magnetic Resonance (HTS by NMR) for the Identification of PPIs Antagonists



Current Topics in Medicinal Chemistry 15(20): 2032-2042



In recent years the ever so complex field of drug discovery has embraced novel design strategies based on biophysical fragment screening (fragment-based drug design; FBDD) using nuclear magnetic resonance spectroscopy (NMR) and/or structure-guided approaches, most often using X-ray crystallography and computer modeling. Experience from recent years unveiled that these methods are more effective and less prone to artifacts compared to biochemical high-throughput screening (HTS) of large collection of compounds in designing protein inhibitors. Hence these strategies are increasingly becoming the most utilized in the modern pharmaceutical industry. Nonetheless, there is still an impending need to develop innovative and effective strategies to tackle other more challenging targets such as those involving protein-protein interactions (PPIs). While HTS strategies notoriously fail to identify viable hits against such targets, few successful examples of PPIs antagonists derived by FBDD strategies exist. Recently, we reported on a new strategy that combines some of the basic principles of fragment-based screening with combinatorial chemistry and NMR-based screening. The approach, termed HTS by NMR, combines the advantages of combinatorial chemistry and NMR-based screening to rapidly and unambiguously identify bona fide inhibitors of PPIs. This review will reiterate the critical aspects of the approach with examples of possible applications.

(PDF emailed within 1 workday: $29.90)

Accession: 057993039

Download citation: RISBibTeXText

PMID: 25986689


Related references

High-throughput nuclear magnetic resonance-based screening. Journal of Medicinal Chemistry 42(13): 2315-2317, 1999

A strategy for high-throughput assay development using leads derived from nuclear magnetic resonance-based screening. Journal of Biomolecular Screening 7(5): 429-432, 2003

Low field nuclear magnetic resonance for rapid quantitation of microalgae lipid and its application in high throughput screening. Sheng Wu Gong Cheng Xue Bao 32(3): 385-396, 2016

Flow injection proton nuclear magnetic resonance spectroscopy combined with pattern recognition methods: Implications for rapid structural studies and high throughput biochemical screening. Analytical Communications 34(11): 339-341, 1997

Identification of nonpeptidic urotensin II receptor antagonists by virtual screening based on a pharmacophore model derived from structure-activity relationships and nuclear magnetic resonance studies on urotensin II. Journal of Medicinal Chemistry 45(9): 1799-1805, April 25, 2002

High resolution ¹⁹F{¹H} nuclear magnetic resonance spectroscopy and liquid chromatography-solid phase extraction-offline ¹H nuclear magnetic resonance spectroscopy for conclusive detection and identification of cyanide in water samples. Journal of Chromatography. A 1284: 88-99, 2013

Identification of novel NaV1.7 antagonists using high throughput screening platforms. Combinatorial Chemistry & High Throughput Screening 15(9): 713-720, 2014

A reactor for high-throughput high-pressure nuclear magnetic resonance spectroscopy. Review of Scientific Instruments 86(10): 104101-104101, 2015

Identification of novel selective P2Y 6 receptor antagonists by high-throughput screening assay. Life Sciences 180: 137-142, 2017

An eight-coil high-frequency probehead design for high-throughput nuclear magnetic resonance spectroscopy. Journal of Magnetic Resonance 170(2): 206-212, 2004

Multiple solenoidal microcoil probes for high-sensitivity, high-throughput nuclear magnetic resonance spectroscopy. Analytical Chemistry 71(21): 4815-4820, 1999

Identification of two antagonists of the scavenger receptor CD36 using a high-throughput screening model. Analytical Biochemistry 400(2): 207-212, 2010

A Multidisciplinary Approach to High Throughput Nuclear Magnetic Resonance Spectroscopy. Sensors 16(6): -, 2016

Identification of small molecule NPR-B antagonists by high throughput screening--potential use in heart failure. Naunyn-Schmiedeberg's Archives of Pharmacology 387(1): 5-14, 2014

Identification of metabotropic glutamate receptor antagonists using an automated high-throughput screening system. Analytical Biochemistry 313(2): 246-254, February 15, 2003